Skip to main content
logo
Goldenwell Biotech, Inc. (GWLL)
OTCMKTS · Delayed Price · Currency is USD
0.7000
0.00 (0.00%)
At close: Aug 20, 2026

Goldenwell Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-0.28-0.3-0.13-0.12-0.99-0.12
Other Operating Activities
0.010.010.0100-
Change in Inventory
0.170.17000.02-0.2
Change in Accounts Payable
-----0.110.11
Change in Unearned Revenue
-00.1-000-
Change in Other Net Operating Assets
-0.01-0.01-0-0-0
Operating Cash Flow
-0.11-0.02-0.12-0.11-1.07-0.21
Operating Cash Flow Growth
------

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--0.120.150.02-
Net Debt Issued (Repaid)
--0.120.150.02-
Issuance of Common Stock
----0.890.17
Other Financing Activities
0.05---0.03--
Financing Cash Flow
0.05-0.120.120.910.17

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-0.07-0.02-00.01-0.17-0.04

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Levered Free Cash Flow
0.010.08-0.08-0.07-0.7-
Unlevered Free Cash Flow
0.010.09-0.08-0.07-0.7-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
0.160.2700-0.09-0.09